Merck Europe B.V.:

Please note that on October 15th, 2024, CFDI sent the Notification of Drug Oversea Inspection results of Recombinant Human Follitropin for Injection to Merck Serono Co., Ltd, the agency of the medicine in China.

If there are any questions, please do not hesitate to contact us as soon.

Contact: Kang Ying

Tel.86-010-68441667

Center for Food and Drug Inspection of NMPA    

 October 18, 2024